FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure

Benzinga2021-11-11

The FDA has signed off Sight Sciences Inc's clinical study to assess investigational higher volume OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Someonelse
2021-11-11
Someonelse
Yay
- sugar87:
  ok
Jess321
2021-11-11
Jess321
Like pls
- Matt_cjx:
  Ok
- JoyJoyce:
  ok
- Jess321:
  like pls
hitithard
2021-11-11
hitithard
Ok
- KidGoat:
  wow
Wolala
2021-11-11
Wolala
K
LplMichelle
2021-11-11
LplMichelle
Please like
- WYY21:
  Done
MarcuzK
2021-11-11
MarcuzK
Like

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1137836759?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-11 20:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137836759","market":"us","top_or_hot":-1,"title":"FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure","media":"Benzinga","content":"<div>\n<p>The FDA has signed off Sight Sciences Inc's clinical study to assess investigational higher volume OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24037340/fda-clears-sight-sciences-trial-of-canaloplasty-combined-with-cataract-surgery-to-lower-ocular-press\">网页链接</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 20:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24037340/fda-clears-sight-sciences-trial-of-canaloplasty-combined-with-cataract-surgery-to-lower-ocular-press><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The FDA has signed off Sight Sciences Inc's clinical study to assess investigational higher volume OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24037340/fda-clears-sight-sciences-trial-of-canaloplasty-combined-with-cataract-surgery-to-lower-ocular-press\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGHT","symbol_name":"Sight Sciences, Inc.","start_time":0,"source_url":"https://www.benzinga.com/news/21/11/24037340/fda-clears-sight-sciences-trial-of-canaloplasty-combined-with-cataract-surgery-to-lower-ocular-press","article_id":"1137836759","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137836759","pubTimestamp":1636634651,"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"The FDA has signed off Sight Sciences Inc's clinical study to assess investigational higher volume O","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SGHT":"Sight Sciences, Inc."},"translate_title":"FDA批准了视力科学的管腔成形术联合白内障手术降低眼压的试验","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGHT":0.9},"content_text":"The FDA has signed off Sight Sciences Inc's clinical study to assess investigational higher volume OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with primary open-angle glaucoma (POAG).\nThe PRECISION trial is designed as a three-armed randomized controlled trial with patients receiving micro-invasive glaucoma surgery (MIGS) interventions in conjunction with cataract surgery (n=459).\nThe devices that will be evaluated in the study are the higher volume OMNI (Sight Sciences) and Glaukos Corp's (NYSE: GKOS) iStent Inject Canal Implant.\nThe PRECISION study will evaluate the safety and efficacy of higher volume OMNI for use in canaloplasty without sequential trabeculectomy.\nThe higher volume OMNI dispenses a higher volume of viscoelastic fluid (21 microliters) higher than the currently marketed OMNI Surgical System (11 microliters).\nFor Q3, Sight Sciencesgenerated revenue of $13.1 million, +51% Y/Y, and gross margin expanded to 84% from 70% a year ago.\nThe growth was primarily driven by an increase in the number of facilities ordering OMNI and utilization per ordering facility during Q3.\nThe Company posted a smaller net loss of $(17.2) million compared to $8.1 million a year ago.\nCash and cash equivalents totaled $271.5 million, and total debt was $32.5 million.\nPrice Action: SGHT shares are up 1.16% at $24.23 during the premarket session on the last check Thursday.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":870526182,"gmtCreate":1636636448845,"gmtModify":1636636501589,"author":{"id":"3572697049328629","authorId":"3572697049328629","name":"Someonelse","avatar":"https://static.tigerbbs.com/565912489d2649d83bea8e52f43f2e6c","vip":1,"crmLevel":7,"crmLevelSwitch":0},"htmlText":"Yay","listText":"Yay","text":"Yay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870526182","repostId":1137836759,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538551,"gmtCreate":1636637551091,"gmtModify":1636637551133,"authorId":4088757711331220,"author":{"id":4088757711331220,"authorId":4088757711331220,"name":"sugar87","avatar":"https://static.tigerbbs.com/8d8982092dc8f3539e5bc2421829c45d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870526182,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":870523956,"gmtCreate":1636636151859,"gmtModify":1636636152226,"author":{"id":"4087638013719750","authorId":"4087638013719750","name":"Jess321","avatar":"https://static.tigerbbs.com/dc86625c205fcfa9eb51b6291af7f62d","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/870523956","repostId":1137836759,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538529,"gmtCreate":1636637371339,"gmtModify":1636637371436,"authorId":3579775660085519,"author":{"id":3579775660085519,"authorId":3579775660085519,"name":"Matt_cjx","avatar":"https://static.tigerbbs.com/caca73862e27552f1ed9c206de3aedd3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870523956,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6538456,"gmtCreate":1636636974286,"gmtModify":1636636974318,"authorId":3582512755660221,"author":{"id":3582512755660221,"authorId":3582512755660221,"name":"JoyJoyce","avatar":"https://static.tigerbbs.com/5bb5d46e6bc286bef17e50a5c3c12d88","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870523956,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":6538292,"gmtCreate":1636636157430,"gmtModify":1636636157464,"authorId":4087638013719750,"author":{"id":4087638013719750,"authorId":4087638013719750,"name":"Jess321","avatar":"https://static.tigerbbs.com/dc86625c205fcfa9eb51b6291af7f62d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870523956,"type":1,"supId":0,"prevId":0,"content":"like <u>pls</u>","text":"like <u>pls</u>","html":"like <u>pls</u>"}],"langContent":"CN"},{"id":870567047,"gmtCreate":1636635840198,"gmtModify":1636635876086,"author":{"id":"3570063321997588","authorId":"3570063321997588","name":"hitithard","avatar":"https://static.tigerbbs.com/309ce7b357018aa7b946332c2fe8725c","vip":1,"crmLevel":8,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870567047","repostId":1137836759,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538244,"gmtCreate":1636635944437,"gmtModify":1636635944472,"authorId":3586744862262534,"author":{"id":3586744862262534,"authorId":3586744862262534,"name":"KidGoat","avatar":"https://static.tigerbbs.com/95862e3968cf51ab3a117700e7f58024","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870567047,"type":1,"supId":0,"prevId":0,"content":"wow","text":"wow","html":"wow"}],"langContent":"CN"},{"id":870564065,"gmtCreate":1636635781479,"gmtModify":1636635865106,"author":{"id":"3582878170475225","authorId":"3582878170475225","name":"Wolala","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870564065","repostId":1137836759,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":870566502,"gmtCreate":1636635545087,"gmtModify":1636635856423,"author":{"id":"3582025954833628","authorId":"3582025954833628","name":"LplMichelle","avatar":"https://static.tigerbbs.com/f3f2fe5070ffb7507fcc119e4bce015e","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870566502","repostId":1137836759,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538175,"gmtCreate":1636635611902,"gmtModify":1636635611935,"authorId":3581836280976117,"author":{"id":3581836280976117,"authorId":3581836280976117,"name":"WYY21","avatar":"https://static.tigerbbs.com/b340cea8de257cef8e4011942078d5fe","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870566502,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"CN"},{"id":870561883,"gmtCreate":1636635234557,"gmtModify":1636635235118,"author":{"id":"3563243258535559","authorId":"3563243258535559","name":"MarcuzK","avatar":"https://static.tigerbbs.com/41fde116200c232379312d26e2768f6e","vip":1,"crmLevel":8,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870561883","repostId":1137836759,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":66,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137836759"}